cyclophosphamidefludarabinehigh-dose interleukin-2AldesleukinUveal melanomaClinigen LimitedUniversity of PittsburghIovance Biotherapeuticsadoptive cell therapy
…usion. Patients received non-myeloablative lymphodepletion with cyclophosphamide and fludarabine, followed by infusion of TIL and high-dose inte…